These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 19271648

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Pharmacologic risk factor treatment of peripheral arterial disease is lacking and requires vascular surgeon participation.
    Bianchi C, Montalvo V, Ou HW, Bishop V, Abou-Zamzam AM.
    Ann Vasc Surg; 2007 Mar; 21(2):163-6. PubMed ID: 17349357
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. A review of simple, non-invasive means of assessing peripheral arterial disease and implications for medical management.
    Ferreira AC, Macedo FY.
    Ann Med; 2010 Mar; 42(2):139-50. PubMed ID: 20156042
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Pharmacologic therapy for peripheral arterial disease and claudication.
    Hiatt WR.
    J Vasc Surg; 2002 Dec; 36(6):1283-91. PubMed ID: 12469066
    [Abstract] [Full Text] [Related]

  • 7. [Drug therapy in peripheral arterial occlusive disease].
    Bollinger A.
    Schweiz Med Wochenschr; 1988 Sep 10; 118(36):1283-9. PubMed ID: 3051339
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. High prevalence of undiagnosed patients with peripheral arterial disease in patients hospitalised for non-vascular disorders.
    Lacroix P, Aboyans V, Voronin D, Le Guyader A, Cautrès M, Laskar M.
    Int J Clin Pract; 2008 Jan 10; 62(1):59-64. PubMed ID: 18028389
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Assessment and management of intermittent claudication: importance of secondary prevention.
    Donnelly R.
    Int J Clin Pract Suppl; 2001 Apr 10; (119):2-9. PubMed ID: 11355275
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Endovascular treatment of peripheral vascular disease.
    Allaqaband S, Solis J, Kazemi S, Bajwa T, American Heart Association, American College of Cardiology.
    Curr Probl Cardiol; 2006 Nov 10; 31(11):711-60. PubMed ID: 17052478
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Peripheral arterial disease: Pathophysiology, risk factors, diagnosis, treatment, and prevention.
    Muir RL.
    J Vasc Nurs; 2009 Jun 10; 27(2):26-30. PubMed ID: 19486852
    [Abstract] [Full Text] [Related]

  • 19. [Use of antithrombotic agents in peripheral arterial diseases].
    Wütschert R, Bounameaux H.
    Arch Mal Coeur Vaiss; 1996 Nov 10; 89(11 Suppl):1551-5. PubMed ID: 9092417
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.